Brief: Evofem Presents Data Detailing Fewer Urinary Tract Infections In Women Using Phexxi
May 6 (Reuters) - Evofem Biosciences Inc EVFM.O :
* EVOFEM PRESENTS DATA DETAILING FEWER URINARY TRACT
INFECTIONS IN
WOMEN USING PHEXXI IN THE PHASE 3 AMPOWER CLINICAL TRIAL
* EVOFEM BIOSCIENCES INC - ADVERSE EVENTS WERE CONGRUENT
WITH
RESULTS FROM OVERALL STUDY FINDINGS
* EVOFEM BIOSCIENCES-NEW DATA FROM PHASE 3 AMPOWER CLINICAL
TRIAL
OF PHEXXI SHOWED WOMEN ENROLLED IN TRIAL HAD FEWER UTIS COMPARED
TO GENERAL POPULATION
Source text for Eikon: ID:nPn3yJ1zka
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting